TG Therapeutics | TGTX - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
AbbVie USD 3.59B 28.65B 2025-12
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 19.52B 1.37B 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Bayer EUR 6.59B 496M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Curis USD 5.61M 1.52M 2025-12
Gilead Sciences USD 645M 70M 2026-03
Infinity Pharmaceuticals USD 1.5M 433K 2023-06
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Novartis USD 4.32B 134M 2026-03
Novavax USD 16.1M 8.48M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
TG Therapeutics USD 148.84M 41.34M 2026-03
Verastem USD 12.45M 2.56M 2025-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03